Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04347226
Title Anti-Interleukin-8 (Anti-IL-8) for Cancer Patients With COVID-19
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Matthew Dallos
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.